ERTEKIN, T. Et Al. 2016. May argyrophilic nucleolar organizing region-associated protein synthesis be used for selecting the most reliable dose of drugs such as rhamnetin in cancer treatments?. BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY , vol.117, no.11 , 653-658.

ERTEKIN, T., Bozkurt, O., Eroz, R., NİSARİ, M., Bircan, D., Nisari, M., ... UNUR, E.(2016). May argyrophilic nucleolar organizing region-associated protein synthesis be used for selecting the most reliable dose of drugs such as rhamnetin in cancer treatments?. BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY , vol.117, no.11, 653-658.

ERTEKIN, Tolga Et Al. "May argyrophilic nucleolar organizing region-associated protein synthesis be used for selecting the most reliable dose of drugs such as rhamnetin in cancer treatments?," BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY , vol.117, no.11, 653-658, 2016

ERTEKIN, Tolga Et Al. "May argyrophilic nucleolar organizing region-associated protein synthesis be used for selecting the most reliable dose of drugs such as rhamnetin in cancer treatments?." BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY , vol.117, no.11, pp.653-658, 2016

ERTEKIN, T. Et Al. (2016) . "May argyrophilic nucleolar organizing region-associated protein synthesis be used for selecting the most reliable dose of drugs such as rhamnetin in cancer treatments?." BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY , vol.117, no.11, pp.653-658.

@article{article, author={Tolga ERTEKİN Et Al. }, title={May argyrophilic nucleolar organizing region-associated protein synthesis be used for selecting the most reliable dose of drugs such as rhamnetin in cancer treatments?}, journal={BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY}, year=2016, pages={653-658} }